Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Niacinamide + glycerin is a topical combination formulation designed to enhance skin barrier function and hydration. Niacinamide, a form of vitamin B3, serves as a precursor to the coenzymes nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP), which are essential for cellular metabolism and the synthesis of epidermal lipids, such as ceramides. By increasing ceramide production, niacinamide strengthens the skin barrier and reduces transepidermal water loss (TEWL). Glycerin is a highly effective humectant that attracts water to the stratum corneum and is transported into skin cells via aquaporin-3 (AQP3) channels, further promoting hydration. Clinical data presented at the AAD 2026 meeting indicates that a spray formulation of this combination significantly increases skin hydration for up to 24 hours and provides psychosocial benefits, including improved mood and well-being.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on niacinamide + glycerin.